Skip to main content
. 2020 Sep 14;11:607. doi: 10.3389/fendo.2020.00607

Table 4.

Assessment of liver fat fraction during the follow-up period.

Total ± completers) VLCK diet LC diet
(n = 39) (n = 20) (n = 19)
% Fat fraction (PDFF)** Mean ± SD (95% CI) Mean ± SD (95% CI) Mean ± SD (95% CI) pa
Baseline 9.53 ± 6.7 (7.5) 10.01 ± 6.74 (7.9) 9.03 ± 6.8 (6.2) 0.6554
2 months 6.70 ± 5.06 (4.3) 5.24 ± 3.81 (3.8) 8.24 ± 5.82 (6.2) 0.0634
Difference −2.83 ± 3.82 (−1.8) −4.77 ± 4.26 (−3.4) −0.79 ± 1.76 (−0.5) 0.0006
pb <0.0001 0.0651
Liver steatosis* n (%) n (%) n (%) pc
Baseline 26(66.7%) 14(70%) 12(63.2%) 0.4547
2 months 16 (41.0%) 6 (30.0%) 10 (52.6%) 0.1509
Improvement 10 (25.6%) 8 (40.0%) 2 (10.5%) 0.0351
No improvement 29 (74.4%) 12 (60.0%) 17 (89.5%)
*

Liver steatosis = PDFF >5.4%.

**

PDFF = liver proton density fat fraction.

a

p-value for comparisons between groups among completers. Student unpaired-sample t-test.

b

p-value for comparisons between baseline and 2 months' follow-up for each group. Student paired-sample t-test.

c

p-value for comparisons between groups among completers χ2-test.